Point of care testing

An inexpensive, smartphone based device could offer a wide range of point-of-care tests

A test powered by your fingertips could bring useful diagnostic tests to low resource settings

A miniature molecular device that gives pathologists in low-resource areas diagnostic capabilities

A beta-glucosidase and lipase could be detected by a biosensor that costs half a cent

A novel diagnostic for lung cancer may simply involves taking a nasal swab

Microfluidic innovations promise a new generation of POCT tools for the pathologist

Why it’s important to establish ground rules and quality for point-of-care testing

A new smartphone laboratory allows pathologists to analyze eight samples simultaneously

Rapid, affordable tests for bacterial infections could reduce overprescription

Founder Elizabeth Holmes admits that direct-to-consumer testing company Theranos’ technology doesn’t work – and wasn’t often used